Get Your 7-Day Free Trial!
All-In-One Screener Dividend Income Portfolio Ben Graham Lost Formula Canadian Faster Growers CEO Buys CEO Buys after Price Drop > 20% Dividend Growth Portfolio Dividend Income Portfolio Fast Growers Hedge Fund Guru Top 10 Aggregated High Quality High Quality Low Capex w ROE ROC min High Quality & Low Capex High Yield Insider Buys Historical High Dividend Yields International Gurus' Top Holdings James Montier Short Screen Margin Decliners Mega Caps Peter Lynch & Warren Buffett Peter Lynch Growth w Lower Valuation Peter Lynch S&L Traded Below Book PFCF Screener Piotroski Score Screener Predictable Companies Profitable predictable margin expanders Stocks Sold w less Cash Good Companies The Stalwarts
All-In-One Screener S&P 500 Map S&P 500 Bubble S&P 500 Aggregate Buffett-Munger Screener Industry Overview Undervalued Predictable Benjamin Graham Net-Net 52-week/3Y/5Y Lows 52-week/3Y/5Y Highs Magic Formula(Greenblatt) Dividend Stocks Peter Lynch Screen S&P500 Grid Predictable Companies Spin Off List Historical Low P/B List Historical Low P/S List High Short Interest Upcoming Special Dividends Delisted Stocks
Model PortfoliosPerformances Undervalued Predictable Buffett-Munger Low P/S Low P/B 52w Low Predictable Broadest Owned Most Weighted
Latest Guru Picks List of Gurus Real Time Picks Guru Portfolio Top 10 Holdings View Guru Bargains Hot Picks Aggregated Portfolio Consensus Picks ETFS Score Board Sector Picks International Picks Industry Trends Geographic Trend Options European Shorting
Buffett Indicator Industry Overview U.S. Treasury Yield Curve Shiller P/E Global Market Valuations Economic Data Shiller P/E by Sectors Buffett Assets Allocation GF Value for SP500 Index
The Dow Jones Industrial Average (DJIA) SP 500 Index Nasdaq Composite Index Gross Domestic Product (GDP) Shiller PE Ratio of Wilshire 5000 over GNP Civilian Unemployment Rate Russell 2000 Small Cap Price Index CBOE Volatility Index (VIX) Total Nonfarm Payrolls: All Employees More...
BAKER BROS. ADVISORS LP Profile
Baker Bros. Advisors is a private hedge fund sponsor that is based out of New York City. The company was established in 2000 by Julian Baker and Felix Baker, who continues to have an active role in the company today acting as its co-managing members. Julian Baker has a business background from Harvard and Felix Baker has a PhD in Immunology from Stanford. The company currently has 25 employees with 11 of them being investment advisory professionals or researchers. Baker Bros. Advisors currently falls into the category of catering to less than 10 clients. The firm utilizes a fundamental driven approach to make its investment decisions, emphasizing life sciences companies. The company holds its investments usually for three years, although its more successful investments are held for longer. Baker Bros. Advisors invests almost exclusively in the health care sector, with a much lesser degree of assets allocated in the industrials sector. The firm’s top holdings currently include Pharmacyclics Inc., which alone makes up almost a fifth of its total asset allocations, Incyte Corporation, Synageva Biopharma Corporation, Seattle Genertics Inc., Salix Pharmaceuticals Inc., Acadia Pharmaceuticals Inc., and Biomarin Pharmaceuticals Inc., with its top ten holdings making up more than three quarters of its total holdings. Baker Bros. Baker Bros. Advisors does not believe in diversifying its portfolio, instead focusing on specific companies that it has deemed to be good holdings and placing concentrated positions in their securities that can generate significant returns in the long term. The company has a current market value of over $12 billion, investing almost all of its total available assets. Advisors’s market value has been increasing significantly over time, growing from its $5 billion market valuation just two years prior in 2013 to well over twice that amount today. Baker Bros. Advisors currently provides its products and services to a variety of university foundations, and families.
BAKER BROS. ADVISORS LP has disclosed 114 total holdings in their latest 13F filing with the SEC for the portfolio date of 2021-06-30. The current portfolio value is calculated to be $22.60 Billion. The turnover rate is 2%.
In BAKER BROS. ADVISORS LP's current portfolio as of 2021-06-30, the top 5 holdings are not including call and put options. BAKER BROS. ADVISORS LP did not buy any new stocks in the current portfolio.
Please visit the "Current Portfolio" tab to see the current and past 13F holdings for BAKER BROS. ADVISORS LP, as well as holding map, valuations for each stock, which positions are undervalued, have low PE Ratios, are considered high quality and recently traded at 52-week lows, etc.
Please visit the "Stock Picks" tab to see the latest guru trades and stock picks for BAKER BROS. ADVISORS LP, which include data from 13F quarterly reports, 13D/G beneficial ownership reports and form 4 insider ownership change reports.
Please visit the "Summary" page to see the top 10 holdings, recent stock picks, performance, sector / industry breakdown details, as well as past holding history summary for BAKER BROS. ADVISORS LP.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names
GuruFocus Affiliate Program: Earn up to $400 per referral. Detailed
GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.
© 2004-2021 GuruFocus.com, LLC. All Rights Reserved.